1Laboratory of Integrative Cancer Immunology (LICI), Center for Cancer Research (CCR), National Cancer Institute (NCI), National Institutes of Health (NIH), Bethesda, Maryland.
School of Pharmacy, Faculty of Medicine, The Chinese University of Hong Kong, Hong Kong SAR, China. Search for other works by this author on: School of Pharmacy, Faculty of Medicine, The Chinese ...
Department of Engineering for Innovation Medicine, University of Verona, Verona, Italy. Search for other works by this author on: Department of Engineering for Innovation Medicine, University of ...
You do not currently have access to this content.
Cancer Res (2025) 85 (15_Supplement): P43.
Cancer Res (2025) 85 (8_Supplement_2): ND11.
Abstract. Paraptosis is a type of programmed cell death characterized by cytoplasmic vacuolation, merging as a potential therapeutic strategy for cancer treatment. Paraptosis has been associated with ...
The combination of anti-TROP2 ADCs with PD-(L)1 inhibitors represents a promising therapeutic strategy, merging targeted therapy with immunotherapy to improve treatment outcomes. Clinical trials are ...
1Department of Oncology, Mayo Clinic, Rochester, Minnesota.
At today’s Senate Health, Education, Labor, and Pensions Committee hearing, nominee for Secretary of the Department of Health and Human Services Robert F. Kennedy (RFK) Jr. refused to renounce his ...
1Neurology Clinic and National Center for Tumor Diseases, University Hospital Heidelberg, Heidelberg, Germany. 2Clinical Cooperation Unit Neurooncology, German Cancer Consortium (DKTK), German Cancer ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results